Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by jeffm34


T.TH

Drug development deal with a Chinese company

Here's a deal just signed by another company https://finance.yahoo.com...

December 13, 2021

T.TH

RE:RE:RE:RE:RE:RE:Many new job postings

The investment community may not notice good news from the cancer trial but...

December 9, 2021

T.TH

NASH news from CYDY

CYTODYN INC (U-CYDY) - News Release   Leronlimab (350 mg) Weekly Use...

November 24, 2021

T.TH

Sortilin research coming out of China

https://www.bjbms.org/ojs/index.php/bjbms/article/view/6601/2416

November 24, 2021

T.TH

RE:Nash partnership deal

Financial Terms Under the terms of the agreement, Arrowhead will receive an...

November 22, 2021

T.TH

Nash partnership deal

https://www.reuters.com/markets/europe/gsk-ties-up-with-arrowhead-develop...

November 22, 2021

T.TH

RE:RE:NASH collaboration

It was part of this deal. It's one of the 3 additional targets thrown in....

November 17, 2021

T.TH

NASH collaboration

https://www.google.ca/amp/s/finance.yahoo.com/amphtml/news/arrowhead...

November 17, 2021

T.TH

RE:RE:RE:RE:RE:RE:RE:Patient Protocol Questions

Very unlikely you will see a responder in the phase 1a. If there is that'...

November 15, 2021

T.TH

RE:RE:RE:RE:RE:Patient Protocol Questions

Based on these unrealistic expectations, hopefully there isn't too big a...

November 15, 2021

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Credit Suisse event now available

What aren't you understanding? I'll get out my crayons and draw you a...

November 12, 2021

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Credit Suisse event now available

It's really not that difficult of a concept to understand but I will...

November 12, 2021

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:Credit Suisse event now available

If THTX can't convince physicians to prescribe egrifta now to treat and...

November 12, 2021

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:Credit Suisse event now available

There is no trial needed to sell into that market right now!  Every...

November 12, 2021

T.TH

RE:RE:RE:RE:RE:Credit Suisse event now available

Exactly! Why waste 6 years and $100M or so chasing NASH in the general...

November 12, 2021

T.TH

RE:RE:RE:Credit Suisse event now available

Why aren't they going after the NASH market in the HIV population right...

November 12, 2021

T.TH

Today’s trading TSX

So after this update there's been a flurry of trading on the TSX. Now up...

November 12, 2021

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Does TH already know the drug works?

Its not POC. It's payable if they decide to continue development based on...

November 2, 2021

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Does TH already know the drug works?

The first development milestone of CAD 2,000,000, or Second Installment, is...

November 2, 2021

T.TH

RE:Does TH already know the drug works?

I think any normal company you would expect to see a good run on some...

October 30, 2021

Featured Company